ELTX
Elicio Therapeutics, Inc.
+0.09 (+5.37%)1.87USD125K成交股數49.0M市值–本益比(近四季)75.1股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.8M | 6.8M | 5.0M | 7.0M | 7.8M | 10.7M | 7.2M | 8.2M | 7.6M | 7.3M | 4.9M | 5.5M |
| 銷售管理費用 | 3.6M | 3.8M | 3.0M | 3.1M | 3.0M | 2.8M | 3.1M | 2.7M | 2.7M | 3.5M | 2.8M | 2.3M |
| 營業利益 | −10.4M-3% | −10.6M-21% | −8.0M-22% | −10.1M-8% | −10.7M+5% | −13.5M+25% | −10.3M+33% | −10.9M+40% | −10.2M | −10.8M | −7.8M | −7.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −8.2M-27% | −11.8M-16% | −10.1M-46% | −10.6M+46% | −11.2M-5% | −14.0M+31% | −18.8M+149% | −7.2M-10% | −11.8M | −10.7M | −7.6M | −8.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.43-51% | -0.65-39% | -0.60-57% | -0.66+3% | -0.87-24% | -1.07-16% | -1.39-47% | -0.64-97% | -1.15 | -1.27 | -2.61 | -24.77 |
| 稀釋股數 | 19.2M | 18.2M | 16.7M | 16.1M | 13.0M | 12.2M | 13.6M | 11.3M | 10.3M | 8.4M | 2.9M | 324K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 23.5M | 14.9M | 20.6M | 22.1M | 18.4M | 17.6M | 26.0M | 3.4M | 11.9M | 14.8M | 21.7M | 8.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | 9.7M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 31.3M | 22.7M | 28.3M | 29.5M | 28.1M | 28.2M | 38.4M | 15.8M | 24.5M | 31.0M | 37.6M | 41.8M |
| 有息負債 | 9.5M | 9.5M | 9.7M | 9.3M | – | 20.0M | – | – | – | – | – | – |
| 總負債 | 23.4M | 24.1M | 24.5M | 27.7M | 19.2M | 39.5M | 57.4M | 17.4M | 19.6M | 17.7M | 14.1M | 2.1M |
| 股東權益 | 7.9M | −1.4M | 3.8M | 1.8M | 8.9M | −11.3M | −19.0M | −1.7M | 4.9M | 13.3M | 23.6M | −110M |
| 負債比 | 74.7% | 106.3% | 86.5% | 93.8% | 68.4% | 140.1% | 149.5% | 110.5% | 80.1% | 57.1% | 37.4% | 5.0% |
| 淨現金(現金 − 有息負債) | 13.9M | 5.5M | 10.9M | 12.8M | – | −2.4M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −11.6M | – | – | −10.1M-17% | – | – | – | −12.1M | – | – | −8.1M |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | 17K |
| 自由現金流 | – | – | – | – | – | – | – | – | −12.1M | – | – | −8.2M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −39.6M | –% | -2.58 | −37.0M |
| FY2024 | – | – | −51.9M | –% | -4.25 | −37.2M |
| FY2023 | – | – | −35.2M | –% | -6.96 | −32.8M |
| FY2022 | 2.3M | -91.9% | −28.2M | -1,225.9% | -89.27 | −22.8M |
| FY2021 | 28.3M | +883.1% | −54.6M | -192.8% | -1.93 | −53.0M |
| FY2020 | 2.9M | – | −80.1M | -2,781.5% | -5.43 | −22.9M |